4.3 Article

Association of baseline platelet count with all-cause mortality after acute myocardial infarction

Journal

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE
Volume 10, Issue 2, Pages 176-183

Publisher

OXFORD UNIV PRESS
DOI: 10.1177/2048872620925257

Keywords

Platelet count; acute myocardial infarction; prognosis

Funding

  1. Research of Korea Centres for Disease Control and Prevention [2018-ER6304-02]
  2. Korea Health Promotion Institute [2018-ER6304-02] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

In patients with acute myocardial infarction (AMI), baseline platelet count showed a U-shaped association with an increased risk of all-cause mortality at two years. Specifically, platelet counts below 150 K/mu L and equal to or greater than 350 K/mu L were positively associated with all-cause mortality.
Background We sought to evaluate baseline platelet count as a prognostic indicator in patients with acute myocardial infarction (AMI). Methods Data of 13,085 patients with AMI were retrieved from a prospective nationwide AMI registry from November 2011 to December 2015. Using Cox hazards models, cumulative risks for adverse outcomes were compared among patients with baseline platelet count of less than 150 K/mu L (lowest quartile), 150 to 249 K/mu L, 250 to 349 K/mu L (reference) and equal to or greater than 350 K/mu L (higher quartile). The primary outcome of interest was all-cause mortality. Secondary outcomes included myocardial infarction, re-hospitalisation for heart failure, and stroke. Results During a median follow-up of 2.1 years, a steep U-shaped association was observed for the occurrence of all-cause mortality (p for non-linearity <0.001). For stroke, a similar U-shaped curve was also seen (p for non-linearity = 0.095). After multiple adjustments, the lowest and higher quartiles of baseline platelet count were positively associated with all-cause mortality (adjusted hazard ratio: 2.120; 95% confidence interval: 1.345-3.341; p = 0.001, and adjusted hazard ratio: 1.642; 95% confidence interval: 0.957-2.817; p = 0.072, respectively). Similar results were observed in sensitivity analyses even after excluding patients with age >= 75 years or patients with heart failure. Conclusions In patients with AMI, baseline platelet count demonstrated a U-shaped association with an increased risk of all-cause mortality at two years. If validated, these findings suggest that baseline platelet count could serve as a preferred prognostic marker in AMI due to its low cost and universal availability.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available